Barb Helfrich
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Cancer Research top 10%
- MicroRNA in disease regulation
Papers in
-
- Lung Cancer Treatments and Mutations 5
- Oncology 3
- HER2/EGFR in Cancer Research 2
- Drug Transport and Resistance Mechanisms 1
- Co-authors
- Paul A. Bunn (14 shared papers)Wilbur A. Franklin (5 shared papers)Daniel C. F. Chan (4 shared papers)Anna E. Barón (3 shared papers)Chan Zeng (3 shared papers)David Raben (5 shared papers)Lynn E. Heasley (3 shared papers)Fred R. Hirsch (2 shared papers)
- Journals
- Lung Cancer (6 papers)Clinical Cancer Research (1 paper)International Journal of Hyperthermia (1 paper)Annals of Oncology (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)
- Partner nations
- United StatesItalyJapan
In The Last Decade
Barb Helfrich
20 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 52
- Pulmonary and Respiratory Medicine 442
- Cancer Research 156
- Oncology 182
- Immunology 59
- Pharmacology 43
Countries citing papers authored by Barb Helfrich
This map shows the geographic impact of Barb Helfrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barb Helfrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barb Helfrich more than expected).
Fields of papers citing papers by Barb Helfrich
This network shows the impact of papers produced by Barb Helfrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barb Helfrich. The network helps show where Barb Helfrich may publish in the future.
Co-authors
The 25 scholars most cited alongside Barb Helfrich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 214 | |
| 2 | 2013 | 210 | |
| 3 | 2008 | 206 | |
| 4 | 2005 | 204 | |
| 5 | Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines. | 1999 | 175 |
| 6 | Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents. | 2001 | 137 |
| 7 | Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux. | 1996 | 97 |
| 8 | 1989 | 67 | |
| 9 | 2004 | 50 | |
| 10 | Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo. | 1998 | 34 |
| 11 | 2004 | 24 | |
| 12 | 2002 | 14 | |
| 13 | Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2. | 1992 | 11 |
| 14 | 2003 | 7 | |
| 15 | 1992 | 3 | |
| 16 | 1997 | 2 | |
| 17 | 1997 | 1 | |
| 18 | 1997 | 1 | |
| 19 | 1997 | 1 | |
| 20 | 1997 | 1 |
About Barb Helfrich
Barb Helfrich is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Immunology, Genetics and Cancer Research, having authored 20 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Immune Cell Function and Interaction (2 papers), HER2/EGFR in Cancer Research (2 papers), Inflammatory mediators and NSAID effects (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper), MicroRNA in disease regulation (1 paper) and Drug Transport and Resistance Mechanisms (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (442 citations), Cancer Research (156 citations), Oncology (182 citations), Immunology (59 citations) and Pharmacology (43 citations). Barb Helfrich has collaborated with scholars based in United States, Italy and Japan. Frequent co-authors include Paul A. Bunn, Wilbur A. Franklin, Daniel C. F. Chan, Anna E. Barón, Chan Zeng, David Raben, Lynn E. Heasley, Fred R. Hirsch, Marileila Varella‐Garcia and Ting‐Chao Chou. Their work appears in journals such as Lung Cancer, Clinical Cancer Research, International Journal of Hyperthermia, Annals of Oncology and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.